Radiation therapy after high-dose chemotherapy with peripheral blood stem cell support for high-risk breast cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 4, 2002, Pages 347-353

  Moreno, Marta ^a   Azinovic, Ignacio ^a   López Picazo, José María ^a   Aramendía, José Manuel ^a   Martínez Monge, Rafael ^a   Beltrán, César ^a   Aristu, José Javier ^a   Rebollo, Joseba ^a   Algarra, Salvador Martín ^a   Fernández, Óscar ^a   Brugarolas, Antonio ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Breast cancer; HDC; Peripheral stem cell support; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; HORMONE; METHOTREXATE; MITOMYCIN C; PACLITAXEL; THIOTEPA;

ADULT; ARTICLE; BLOOD TOXICITY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; POSTOPERATIVE CARE; RADIATION DOSE; RADIATION INJURY; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0036337836     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200208000-00006     Document Type: Article

References (32)

1. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base
2. High-dose chemotherapy and autologous bone marrow support for breast cancer. Review
3. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes
4. The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer
5. High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes
6. Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant
7. Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy
8. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial
9. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
10. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis
11. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer
12. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer
13. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: Sequencing, timing, and outcome
14. Effect of delay in radiation in the combined modality treatment of breast cancer
15. The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: A preliminary analysis
16. Reporting results of cancer treatment
17. Late effects toxicity scoring: The SOMA scale
18. Non-parametric estimation from incomplete observations
19. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer
20. Results from a randomized adjuvant breast cancer study with high-dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailores FEC therapy
21. A prospective, randomized comparison of two doses of combination alkylating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes: Preliminary results of CALGB 9082/SWOG 9114/NCIC MA-13
22. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy
23. The role of radiotherapy in the management of operable locally advanced breast carcinoma: Results of a randomized trial by the Eastern Cooperative Oncology Group
24. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial
25. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
26. Cancer of the breast
27. Postoperative radiotherapy in the treatment of breast cancer: Results of the NSABP clinical trial
28. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy
29. Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy
30. Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa
31. High-dose chemotherapy regimens for solid tumors